Current position:Home > Selling > GSK2636771

GSK2636771

  • CAS No.: 1372540-25-4
  • Purity: >98%
  • Weight: 433.42359
  • Formula: C22H22F3N3O3
  • Place of Orign: Princeton,New Jersey,United States
Ms.James Gao

Supplier Details

View the Seller's Store
Product Details
Company Profile

Item specifics

  • Product Name.:GSK2636771
  • CAS No: 1372540-25-4
  • Weight: 433.42359
  • Formula: C22H22F3N3O3
  • Density: 1.38

Details

GSK2636771GSK2636771 is a potent, orally bioavailable, PI3Kβ-selective inhibitor, sensitive to PTEN null cell lines.

IC50 value:

Target:

in vitro: GSK-2636771 shows selectively inhibitory activity in PTEN null cell lines (human prostate adenocarcinoma PC-3 and breast cancer HCC70) with EC50 of 36 nM and 72 nM, respectively.

Target:HDAC

Product Links:http://www.medchemexpress.cn/gsk2636771.html

Permanent link:http://www.medchemexpress.com/GSK2636771.html

Permanent link:

Company Related ProductsView the Seller's Products

GSK2606414

CAS No: 1337531-36-8

Purity: >98%

Min quantity: null null

Price: null ~ null null

Description: GSK2606414 GSK2606414 is an orally available, potent, and selective PERK inhibitor with an IC50 of 0.4 nM. IC50 Value: 0.4 nM [1] Target:PERK GSK2606414 inhibits PERK activation in cells and inhibits the growth of a human tumor xenograft in mice. Tar...

Detail more >>

GSK126

CAS No: 1346574-57-9

Purity: >98%

Min quantity: null null

Price: null ~ null null

Description: GSK126 GSK126 is a potent, highly selective, S-adenosyl-methionine-competitive, small-molecule inhibitor of EZH2 methyltransferase with Ki value of 0.5 nM. IC50 Value: 0.5 nM (Ki) Target: EZH2 in vitro: Although GSK126 induced loss of H3K27me3 indepe...

Detail more >>
Send message to this supplier

CAS No:1372540-25-4 2-methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-<br />ylbenzimidazole-4-carboxylic acid

- Enter between 20 to 3,000 characters. English only.
Your message must be between 20-2000 characters.English only.

Look for similar items

  • Home > Organic Intermediates > Pharmaceutical Intermediates